C. Michael Stein
-
Twelve at Vanderbilt are among world’s highly cited researchers
Twelve current investigators at Vanderbilt University Medical Center and Vanderbilt University are on this year’s list of scientists whose papers have been cited the most frequently by other researchers. Read MoreNov 15, 2023
-
Kudos: Read about faculty, staff, student and alumni awards, appointments and achievements
Read about Vanderbilt faculty, staff, student and alumni awards, appointments and achievements. Read MoreDec 17, 2018
-
Vanderbilt researchers’ papers among those most cited
Eight current faculty members at Vanderbilt have made this year’s list of scientists whose papers have been cited most frequently by other researchers. Read MoreDec 7, 2017
-
Grant bolsters rheumatoid arthritis research
C. Michael Stein, MBChB., and his colleagues at Vanderbilt University Medical Center have received a five-year, $1.35 million award from the Arthritis Foundation to develop new biomarkers for rheumatoid arthritis that also may revolutionize treatment. Read MoreFeb 25, 2016
-
Does fish oil help prevent A-fib?
Growing evidence suggests that fish oil, thought to directly prevent inflammation, oxidative stress and heart disease, may have limited clinical utility. Read MoreJan 9, 2015
-
‘Good Cholesterol’ Levels Don’t Tell the Whole Story
High-density lipoprotein (HDL) is known as “good cholesterol” because elevated levels protect against heart attacks and plaque buildup. However, in some cases HDL may not function properly and may actually accelerate the disease. Read MoreDec 23, 2014
-
Major grant spurs deeper look into ‘good cholesterol’
In some cases, HDL, the "good cholesterol," may not function properly and may actually accelerate atherosclerosis. Read MoreAug 21, 2014
-
AHA grant creates coalition to prevent heart disease, stroke
Vanderbilt University Medical Center is one of four institutions that are part of a new research network aimed at preventing heart disease and stroke, the two leading causes of death in the world. Read MoreJul 10, 2014
-
Common antibiotic found to pose increased heart risk
Vanderbilt researchers have discovered a rare, but important risk posed by the antibiotic azithromycin, commonly called a “Z-pack.” The study found a 2.5-fold higher risk of death from cardiac arrhythmia in the first five days of taking azithromycin when compared with another common antibiotic or no antibiotics at all. Read MoreMay 21, 2012